Bluejay Diagnostics, Inc.
BJDX
$4.00
-$0.03-0.74%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.76M | 8.06M | 2.66M | 2.21M | 5.08M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 811.90K | 960.00K | 788.60K | 747.30K | 1.45M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | 265.10K | -- |
Total Current Assets | 6.57M | 9.02M | 3.45M | 3.22M | 6.53M |
|
|||||
Total Current Assets | 6.57M | 9.02M | 3.45M | 3.22M | 6.53M |
Net Property, Plant & Equipment | 1.76M | 1.82M | 1.60M | 1.62M | 1.69M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 23.60K | 24.40K | 25.20K | 28.70K | 29.90K |
Total Assets | 8.35M | 10.86M | 5.08M | 4.87M | 8.25M |
|
|||||
Total Accounts Payable | 316.70K | 490.10K | 271.80K | 491.50K | 755.90K |
Total Accrued Expenses | 616.30K | 1.29M | 1.10M | 1.11M | 1.63M |
Short-term Debt | -- | 147.40K | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 116.30K | 133.40K | 150.60K | 167.80K | 173.50K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 240.00K |
Total Other Current Liabilities | -- | -- | -- | -- | 240.00K |
Total Current Liabilities | 1.05M | 2.06M | 1.53M | 1.77M | 2.80M |
|
|||||
Total Current Liabilities | 1.05M | 2.06M | 1.53M | 1.77M | 2.80M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | 147.40K | -- | -- | -- |
Capital Leases | 139.70K | 161.30K | 182.10K | 202.30K | 233.30K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.19M | 2.22M | 1.71M | 1.97M | 3.03M |
|
|||||
Common Stock & APIC | 40.40M | 40.40M | 32.65M | 29.85M | 29.86M |
Retained Earnings | -33.24M | -31.75M | -29.28M | -26.95M | -24.65M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 7.16M | 8.64M | 3.37M | 2.89M | 5.21M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 7.16M | 8.64M | 3.37M | 2.89M | 5.21M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 7.16M | 8.64M | 3.37M | 2.89M | 5.21M |
|